MedPath

Anaesthetist-Controlled Compared with Effect-site Patient-maintained Target-controlled Sedation (ACCEPTS)

Not Applicable
Completed
Conditions
Hip or knee replacements
Surgery
Other joint disorders
Registration Number
ISRCTN29129799
Lead Sponsor
ottingham University Hospitals NHS Trust
Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30760311 protocol 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34852928/ (added 03/12/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Listed to undergo elective primary hip or knee arthroplasty under spinal anaesthesia
2. Expressing a pre-operative preference for sedation during surgery
3. Able to communicate in written and spoken English
4. Capable of giving informed consent
5. Age >18 years

Exclusion Criteria

1. Allergy to propofol
2. Medical contraindication to spinal anaesthesia (for example local infection at injection site, patient refusal, allergy to local anaesthetic agent, untreated systemic infection, untreated coagulopathy)
3. Expressing pre-operative preference for surgery to be performed awake or under general anaesthesia.
4. Inability to use handheld trigger system of the PMPSD
5. Pregnant or breastfeeding

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of propofol consumption. The total propofol consumption in milligrams received by the patient using the PMPSD will be recorded every second throughout the sedation period on a Dell 5414 Latitude Rugged laptop. At the end of surgery, consumption will be expressed as the total number of milligrams of propofol delivered, adjusted for body weight and expressed as a rate across the duration of the sedation period (unit: milligrams per kilogram per hour). The sedation period is defined from the time of commencement of sedation by the supervising clinical anaesthetist up until the time when surgery ends, being when clips are applied by the operating surgeon to the surgical incision.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath